Various mechanisms and pathways, such as caspase‐8, TRPV1, and IRAK‐M, have been found to affect the activation of NLRP3 inflammasomes in MG and MФ, playing critical roles in the development of MS and CNS inflammation. This evidence concerns the gene NLRP3 and myeloid sarcoma.